USDCC was pleased to submit written comments in support of the U.S. Food and Drug Administration's (FDA) draft guidance on Donor Eligibility for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps).
USDCC addresses criticisms of Colorado's Donor Conceived Persons Protection Act and proposed rules.
The Colorado General Assembly gave final approval to amend the Donor Conceived Persons Protection Act to update definitions and provide more clarity as the legislation moves closer to going into effect in 2025.
USDCC joins others to express concerns about the potential implications of the Supreme Court of Alabama’s opinion in LePage v. The Center for Reproductive Medicine, P.C.
USDCC announces the election of its 2024 executive board and its expansion through a new department.
for immediate release Jan. 4, 2023 – U.S. Donor Conceived Council (USDCC) elected its 2023 executive board on January 3, 2023. The 501(c)(3) nonprofit is an all-volunteer group devoted to education and advocacy regarding the […]